<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li C</submitter><funding>Fonds de Recherche du Québec - Santé</funding><funding>Michael Smith Foundation for Health Research</funding><funding>Ministry of Science, ICT and Future Planning</funding><funding>National Research Foundation</funding><funding>Genome Canada</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>134-147</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7820726</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>108(1)</volume><pubmed_abstract>The ubiquitin-proteasome system facilitates the degradation of unstable or damaged proteins. UBR1-7, which are members of hundreds of E3 ubiquitin ligases, recognize and regulate the half-life of specific proteins on the basis of their N-terminal sequences ("N-end rule"). In seven individuals with intellectual disability, epilepsy, ptosis, hypothyroidism, and genital anomalies, we uncovered bi-allelic variants in UBR7. Their phenotype differs significantly from that of Johanson-Blizzard syndrome (JBS), which is caused by bi-allelic variants in UBR1, notably by the presence of epilepsy and the absence of exocrine pancreatic insufficiency and hypoplasia of nasal alae. While the mechanistic etiology of JBS remains uncertain, mutation of both Ubr1 and Ubr2 in the mouse or of the C. elegans UBR</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism.</pubmed_title><pmcid>PMC7820726</pmcid><funding_grant_id>NRF-2020R1A5A1019023</funding_grant_id><funding_grant_id>MOP142243</funding_grant_id><funding_grant_id>NRF-2016R1A2B3011389</funding_grant_id><pubmed_authors>Kwon YT</pubmed_authors><pubmed_authors>Neas K</pubmed_authors><pubmed_authors>Stanley V</pubmed_authors><pubmed_authors>Campeau PM</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Rosenfeld JA</pubmed_authors><pubmed_authors>Al Mutairi F</pubmed_authors><pubmed_authors>Gleeson JG</pubmed_authors><pubmed_authors>Heo AJ</pubmed_authors><pubmed_authors>Wagner M</pubmed_authors><pubmed_authors>Rousseau J</pubmed_authors><pubmed_authors>Kondratev C</pubmed_authors><pubmed_authors>Zaki MS</pubmed_authors><pubmed_authors>Leroux MR</pubmed_authors><pubmed_authors>Bacino CA</pubmed_authors><pubmed_authors>Beauregard-Lacroix E</pubmed_authors><pubmed_authors>Graham BH</pubmed_authors><pubmed_authors>Wenzel M</pubmed_authors><pubmed_authors>Al Deiab H</pubmed_authors></additional><is_claimable>false</is_claimable><name>UBR7 functions with UBR5 in the Notch signaling pathway and is involved in a neurodevelopmental syndrome with epilepsy, ptosis, and hypothyroidism.</name><description>The ubiquitin-proteasome system facilitates the degradation of unstable or damaged proteins. UBR1-7, which are members of hundreds of E3 ubiquitin ligases, recognize and regulate the half-life of specific proteins on the basis of their N-terminal sequences ("N-end rule"). In seven individuals with intellectual disability, epilepsy, ptosis, hypothyroidism, and genital anomalies, we uncovered bi-allelic variants in UBR7. Their phenotype differs significantly from that of Johanson-Blizzard syndrome (JBS), which is caused by bi-allelic variants in UBR1, notably by the presence of epilepsy and the absence of exocrine pancreatic insufficiency and hypoplasia of nasal alae. While the mechanistic etiology of JBS remains uncertain, mutation of both Ubr1 and Ubr2 in the mouse or of the C. elegans UBR</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-04-07T17:53:07.887Z</modification><creation>2022-02-10T18:21:12.551Z</creation></dates><accession>S-EPMC7820726</accession><cross_references><pubmed>33340455</pubmed><doi>10.1016/j.ajhg.2020.11.018</doi></cross_references></HashMap>